You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 12, September 24, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Quality of Care
 •Patient Safety/ Medical Error
 •Hematology/ Hematologic Malignancies
 •Hematology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Leukoreduction vs Buffy-Coat Depletion and the Safety of Blood Transfusion

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Hébert and colleagues1 found that a national universal leukoreduction program for red blood cell (RBC) transfusion reduced the rates of mortality and morbidity after RBC transfusions in high-risk patients. Although the authors state that RBCs transfused in the period before the introduction of the policy were stored in an additive solution, they do not indicate whether any of these units underwent depletion of the buffy coat. It also would be important to know about clinical use of microaggregate filters at the bedside.

Furthermore, RBCs that are not leukoreduced by filtration may vary in their risk of transfusion reactions. Buffy coat–depleted units contain about 70% fewer white blood cells and fewer microaggregates than does blood that has not been depleted of the buffy coat.2 Blood that is neither filtered nor depleted of the buffy coat, but which is transfused through a microaggregate filter, will contain fewer platelet . . . [Full Text of this Article]

Jonathan P. Wallis, MBBS, FRCPath
Department of Haematology
Freeman Hospital
Newcastle upon Tyne, England



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions
, , , , , , , , , , , , , and
JAMA. ;289():1941-1949.
FULL TEXT  

Leukoreduction vs Buffy-Coat Depletion and the Safety of Blood Transfusion--Reply
and
JAMA. ;290():1580-1580.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.